|
|
||||
|
Friday, September 23
by
Alex Hsieh on behalf of Professor Henry Wang
on Fri 23 Sep 2005 05:32 PM EDT
Healthorbit.ca
by
Alex Hsieh on behalf of Professor Henry Wang
on Fri 23 Sep 2005 05:31 PM EDT
On Sept. 15, the US Food and Drug Administration (Rockville, MD) proposed current good manufacturing practices (CGMPs) rules to govern drugs for positron emission tomography (PET) and simultaneously issued a draft guidance, “PET Drug Products—Current Good Manufacturing Practice.”
Link to Article PharmTech ePT: pharmtech.com |
Search
Links
|
|||
